tiprankstipranks
Vicapsys Life Sciences Inc (VICP)
OTHER OTC:VICP
US Market

Vicapsys Life Sciences (VICP) Price & Analysis

Compare
0 Followers

VICP Stock Chart & Stats


---

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.23%99.77%
Insiders
Mutual Funds
0.23% Other Institutional Investors
99.77% Public Companies and
Individual Investors

VICP FAQ

What was Vicapsys Life Sciences Inc’s price range in the past 12 months?
Vicapsys Life Sciences Inc lowest stock price was $0.42 and its highest was $14.00 in the past 12 months.
    What is Vicapsys Life Sciences Inc’s market cap?
    Vicapsys Life Sciences Inc’s market cap is $76.07M.
      When is Vicapsys Life Sciences Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Vicapsys Life Sciences Inc’s earnings last quarter?
      Currently, no data Available
      Is Vicapsys Life Sciences Inc overvalued?
      According to Wall Street analysts Vicapsys Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Vicapsys Life Sciences Inc pay dividends?
        Vicapsys Life Sciences Inc does not currently pay dividends.
        What is Vicapsys Life Sciences Inc’s EPS estimate?
        Vicapsys Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Vicapsys Life Sciences Inc have?
        Vicapsys Life Sciences Inc has 32,371,300 shares outstanding.
          What happened to Vicapsys Life Sciences Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Vicapsys Life Sciences Inc?
          Currently, no hedge funds are holding shares in VICP
          ---

          Company Description

          Vicapsys Life Sciences Inc

          Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. Its initial pipeline products include type 1 diabetes, post-surgical abdominal adhesion formation, and post-trauma keloid formation. The company was founded on December 26, 1996 and is headquartered in Cumming, GA.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Ibio
          Curis
          Anavex Life Sciences
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis